Correction

Published on 06 Feb 2024

Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

in Vaccines and Molecular Therapeutics

Hoi Man Ng
Chon Lok Lei
Siyi Fu
Enqin Li
Sek In Leong
Chu Iong Nip
Nga Man Choi
Kai Seng Lai
Xi Jun Tang
Chon Leng Lei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1375028

482 views

Original Research

Published on 05 Feb 2024

Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva

in Vaccines and Molecular Therapeutics

Stephan Winklmeier
Heike Rübsamen
Ceren Özdemir
Paul R. Wratil
Gaia Lupoli
Marcel Stern
Celine Schneider
Katharina Eisenhut
Samantha Ho
Hoi Kiu Wong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1330864

1,448 views

Original Research

Published on 02 Feb 2024

A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses

in Vaccines and Molecular Therapeutics

James Tristan Gordy
Yinan Hui
Courtney Schill
Tianyin Wang
Fengyixin Chen
Kaitlyn Fessler
Jacob Meza
Yangchen Li
Alannah D. Taylor
Rowan E. Bates

Frontiers in Immunology

doi 10.3389/fimmu.2024.1292059

1,717 views
1 citation

Review

Published on 01 Feb 2024

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

in Vaccines and Molecular Therapeutics

Bowen Lu
Jing Ming Lim
Boyue Yu
Siyuan Song
Praveen Neeli
Navid Sobhani
Pavithra K
Srinivasa Reddy Bonam
Rajendra Kurapati
Junnian Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1332939

5,605 views
5 citations

Original Research

Published on 01 Feb 2024

Age-dependent acquisition of IgG antibodies to Shigella serotypes—a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination

in Vaccines and Molecular Therapeutics

Melissa C. Kapulu
Esther Muthumbi
Edward Otieno
Omar Rossi
Pietro Ferruzzi
Francesca Necchi
Alessandra Acquaviva
Laura B. Martin
Benedict Orindi
Kennedy Mwai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1340425

1,618 views

Correction

Published on 01 Feb 2024

Corrigendum: Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants

in Vaccines and Molecular Therapeutics

Franciane Mouradian Emidio Teixeira
Luana de Mendonça Oliveira
Anna Cláudia Calvielli Castelo Branco
Ricardo Wesley Alberca
Emanuella Sarmento Alho de Sousa
Bruno Henrique de Sousa Leite
Wenny Camilla dos Santos Adan
Alberto José da Silva Duarte
Roberto Dias Lins
Maria Notomi Sato

Frontiers in Immunology

doi 10.3389/fimmu.2024.1376059

448 views

Original Research

Published on 31 Jan 2024

Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

in Vaccines and Molecular Therapeutics

Jennifer Serwanga
Violet Ankunda
Joseph Ssebwana Katende
Claire Baine
Gerald Kevin Oluka
Geoffrey Odoch
Hellen Nantambi
Susan Mugaba
Angella Namuyanja
Ivan Ssali

Frontiers in Immunology

doi 10.3389/fimmu.2024.1348905

1,475 views
1 citation

Original Research

Published on 30 Jan 2024

Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species

in Vaccines and Molecular Therapeutics

Michiel M. Harmsen
Bart Ackerschott
Hans de Smit

Frontiers in Immunology

doi 10.3389/fimmu.2024.1346328

2,776 views
1 citation

Original Research

Published on 30 Jan 2024

Selection of vaccine-candidate peptides from Mycobacterium avium subsp. paratuberculosis by in silico prediction, in vitro T-cell line proliferation, and in vivo immunogenicity

in Vaccines and Molecular Therapeutics

Kari Lybeck
Stig Tollefsen
Heidi Mikkelsen
Siri Kulberg Sjurseth
Claus Lundegaard
Claus Aagaard
Ingrid Olsen
Gregers Jungersen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1297955

2,606 views

Systematic Review

Published on 30 Jan 2024

CAR Immunotherapy for the treatment of infectious diseases: a systematic review

in Vaccines and Molecular Therapeutics

Elena Morte-Romea
Cecilia Pesini
Galadriel Pellejero-Sagastizábal
Santiago Letona-Giménez
Luis Martínez-Lostao
Silvia Loscos Aranda
Carla Toyas
Sergio Redrado
Elena Dolader-Ballesteros
Maykel Arias

Frontiers in Immunology

doi 10.3389/fimmu.2024.1289303

4,218 views
2 citations

Brief Research Report

Published on 29 Jan 2024

Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

in Vaccines and Molecular Therapeutics

Annkristin Heine
Niels A. W. Lemmermann
Chrystel Flores
Janine Becker-Gotot
Natalio Garbi
Peter Brossart
Christian Kurts

Frontiers in Immunology

doi 10.3389/fimmu.2024.1338499

1,512 views

Original Research

Published on 26 Jan 2024

Immune response following a two-dose schedule of bivalent HPV vaccination among girls and boys

in Vaccines and Molecular Therapeutics

Marit Middeldorp
Janneke W. Duijster
Jan van de Kassteele
Fiona R.M. van der Klis
Hester E. de Melker

Frontiers in Immunology

doi 10.3389/fimmu.2024.1327770

1,156 views

Original Research

Published on 26 Jan 2024

Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects

in Vaccines and Molecular Therapeutics

Valentina Laquintana
Carla Mottini
Francesco Marchesi
Benedetta Marcozzi
Irene Terrenato
Eleonora Sperandio
Luisa de Latouliere
Francesca Carrieri
Fulvia Pimpinelli
Martina Pontone

Frontiers in Immunology

doi 10.3389/fimmu.2023.1221587

1,653 views

Review

Published on 24 Jan 2024

Clinical research on RSV prevention in children and pregnant women: progress and perspectives

in Vaccines and Molecular Therapeutics

Xuejia Gong
Erdan Luo
Li Fan
Wanggang Zhang
Yan Yang
Yuhua Du
Xiao Yang
Shasha Xing

Frontiers in Immunology

doi 10.3389/fimmu.2023.1329426

3,109 views
2 citations

Original Research

Published on 23 Jan 2024

A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus

in Vaccines and Molecular Therapeutics

Yating Wang
Shijia Liu
Boshuo Li
Xinyao Sun
Qi Pan
Yuxin Zheng
Jia Liu
Yongqiang Zhao
Jingyu Wang
Liming Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1336239

2,711 views

Review

Published on 23 Jan 2024

Nanobodies: a promising approach to treatment of viral diseases

in Vaccines and Molecular Therapeutics

Vitória Meneghetti Minatel
Carlos Roberto Prudencio
Benedito Barraviera
Rui Seabra Ferreira

Frontiers in Immunology

doi 10.3389/fimmu.2023.1303353

4,174 views
4 citations

Navigation group

Articles

Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva

A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

Age-dependent acquisition of IgG antibodies to Shigella serotypes—a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination

Corrigendum: Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants

Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species

Selection of vaccine-candidate peptides from Mycobacterium avium subsp. paratuberculosis by in silico prediction, in vitro T-cell line proliferation, and in vivo immunogenicity

CAR Immunotherapy for the treatment of infectious diseases: a systematic review

Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

Immune response following a two-dose schedule of bivalent HPV vaccination among girls and boys

Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects

Clinical research on RSV prevention in children and pregnant women: progress and perspectives

A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus

Nanobodies: a promising approach to treatment of viral diseases